Clinical features of suspected pediatric patients with 2019 novel coronavirus infection and the role of procalcitonin in early differential diagnosis ===================================================================================================================================================== * Denggao Peng * Jing Zhang * Yingqi Xu * Zhichao Liu * Pengyao Wu ## Abstract A retrospective analysis was performed.39 (50.6%) of 77 suspected cases were comfirmed, 4 (5.2%) of them had viral coinfection. Compared with non-2019-nCoV group(n=33),2019-nCoV confirmed group (n=39) had fewer fever and symptoms of acute respiratory infection (ARI), more asymptomatic and more family cluster infections. While computed tomography (CT) had more positive findings of viral pneumonia. Age and gender were insignificant. PCT (0.05[0.029-0.076] vs 0.103[0.053-0.21];P<.001) of 2019-nCoV alone group (n=35) was significantly reduced. While compared with coinfection group (n=4), PCT (0.05[0.029–0.076] vs 0.144[0.109–2.26];P=.003) was also statistically reduced. The area under curve (AUC) of receiver operating characteristic (ROC) of overall model is 0.817 ([95%CI] [0.719-0.916];P<.001). The AUC of PCT is 0.792 ([0.688-0.896];P<.001). The cut-off value is 0.1 ng/mL. Asymptoms or mild symptoms, positive CT findings and family cluster infection are the main clinical features of pediatric 2019-nCoV infection. With moderate efficacy, PCT can provide an important basis for differentiating 2019-nCoV alone and other viral infection or viral coinfection. Keywords * 2019 novel coronavirus * Procalcitonin * Pediatric * differential diagnosis * suspected infection ## Introduction Children are naturally susceptible to various respiratory viruses due to their imperfect immune functions. Since the outbreak of 2019 novel coronavirus (2019-nCoV) began in Wuhan city, Hubei province, China,1,2 more than 2,000 pediatric cases have been reported nationwide in just over two months.3 Limited by accuracy of nucleic acid detection,4 relative reagent shortage and non-specificity of imaging findings, early differential diagnosis of suspected pediatric patients is difficult to some extent. Obviously, this has a serious impact on timely triage and the following reasonable treatment. At present, a growing number of studies have focused on diagnosis and treatment of confirmed cases, but few data are available on clinical characteristics and early identification of suspected pediatric patients with 2019-nCoV infection as a special population. As a traditional biomarker, procalcitonin (PCT) have shown superior value in differentiating bacterial and viral infections as well as bacterial coinfections. However, the role of PCT in identifying between viruses and viruses or viral coinfection in children remain unknown. We aimed to investigate and identify the clinical features and evaluate the role of PCT in early differential diagnosis, so as to provide a basis for the follow-up timely and reasonable treatment and effective implementation of prevention and control measures. ## Materials and Methods ### Definition and classification Children are defined as being less than 18 years old. Referring to the guidelines on the diagnosis and treatment of 2019-nCoV infected pneumonia (the sixth edition draft) issued by the National Health Commission of China.5 Suspected cases are defined as having a clear epidemiological exposure, with or without clinical manifestations, and with or without positive CT findings. Epidemiological exposure includes close contact with confirmed cases, and or living or traveling in endemic areas (especially Hubei province), and or presence of confirmed case in their residential communities. If nasopharyngeal swab or anal swab specimens tested positive for 2019-nCoV nucleic acid using real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay, suspected case is identified as a confirmed case. Fever was recognized when body temperature is higher than or equal to 37.3. Symptoms of ARI includes nasal congestion, runny nose, sneezing, sore throat, cough, expectoration, chest pain, dyspnea, etc. All chest computed tomography (CT) images were reviewed by two experienced pediatric radiologists. If unilateral or bilateral lung fields have any of the features as follows:(a) ground glass opacities;(b) consolidations with surrounding halo sign;(c) nodules;(d) residual fiber strips. The result is defined as positive CT findings of viral pneumonia.6 Family cluster infection was defined as the occurrence of any of the following criteria in 2 or more family members within a period of less than 1 week: (a) fever;(b) symptoms of acute respiratory tract infection;(c) positive CT findings of viral pneumonia. ### Data collection We conducted a retrospective study on all clinical and laboratory data. From Jan 22nd to Mar 1st, all suspected pediatric patients were admitted to the Third People’s Hospital of Shenzhen, and relevant examinations were completed as routine precedures, and clinical and laboratory data of the first day after admission were collected. Based on laboratory pathogen identification results including 2019-nCoV, influenza A, B (INF A, INF B), respiratory syncytial virus (RSV), mycoplasma pneumoniae (MP), and bacteria, all cases were divided into the 2019-nCoV confirmed group and the non-2019-nCoV group. 2019-nCoV confirmed group was further divided into 2019-nCoV alone and coinfection group according to whether they were coinfected, and the differences between the groups were compared. Inclusion criteria: all suspected pediatric cases. Exclusion criteria of the non-2019-nCoV group:(a) pathogen identified as bacteria or MP; (b) coinfection; (c) PCT > 0.5 ng/mL.7 ### Statistical Analysis All analyses were conducted by using of IBM Statistical Product and Service Solutions software Version 24 (SPSS Inc, Chicago, IL). Continuous variables were summarized as the median with their interquartile ranges (IQRs) or mean with standard deviations (SDs), median [IQR] or [mean ±SD], depending on whether their distributions were normal or not. Comparisons of categorical variables were performed using the Pearson Chi-square test. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for statistically significant variables. The parametric tests (independent sample Student t-test) or non-parametric tests (Mann-Whitney U test or Kruskal-Wallis test) were used to analyze variables. Variables with p<0.2 in the laboratory data analysis were entered into a multivariate logistic regression model. Model fitness was assessed with the Hosmer-Lemeshow goodness-of-fit test. Analysis of the area under curve (AUC) of receiver operating characteristic curve (ROC) was constructed to assess the differentiating performance. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) were also determined. P<.05 was considered as statistically significant in all tests if applied. ## Results From Jan 22nd to Mar 1st, a total of 77 suspected pediatric patients were admitted, and 39 (50.6%) were confirmed with 2019-nCoV infection, including 3 (3.9%) cases of RSV coinfection, and 1 (1.3%) case with INF B coinfection. 5(6.5%) of 38 (49.4%) cases of non-2019-nCoV infection were excluded by laboratory results and CT scan, consisting of 3 (3.9%) cases with PCT greater than 0.5 ng/mL, were considered as bacterial infection, and 2 (2.6%) cases were considered as MP coinfection (Supplement Table 1). The including 33 (42.9%) patients consisted of 3 (3.9%) cases of INF A, 2 (2.6%) cases of INF B, 9 (11.7%) cases of RSV and 19 (18.2%) cases of unidentified non-bacterial pathogens. View this table: [Table 1:](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/T1) Table 1: Clinical data analysis between 2019-nCoV confirmed and non-2019-nCoV group Compared with non-2019-nCoV group (n=33), 2019-nCoV confirmed group (n=39) had fewer fever(OR[95%CI]0.467[0.314-0.694]; P<.001) and symptoms of ARI (0.533[0.36-0.788];P=.001), more asymptomatic (13.568[1.895-96.729];P<.001), and more family cluster infections (5.077 [2.224-11.591];P<.001), while chest CT had more positive findings of viral pneumonia (1.822[1.143-2.906];P=.008). Age (6.9[3.6-10.5] vs 5[2.1-7.6];P=.088) and gender (43.6% vs 57.6%;P=.344) were statistically insignificant (Table 1). Among all of 4 coinfection cases, 4 had fever and symptoms of ARI, 3 had positive CT findings and 1 was family cluster infection (Supplement Table 1). Compared with non-2019-nCoV (n=33) and coinfection (n=4) group, 2019-nCoV alone (n=35) group had significant statistical differences in PCT (0.05[0.029-0.076] vs 0.103[0.053-0.21] and 0.144[0.109-2.26]; P<.001,=.003), percentage of neutrophil (N%) (40.9[30-48.5] vs 54.8[41.4-67.5];P=.007), percentage of lymphocyte (L%) (45.3[39.2-56.6] vs 33.2[22.7-42.5];P=.001), neutrophil count (NC) (2.25[1.43-3.53] vs 3.33[2.8-5.18];P=.014), high sensitivity C-reactive protein (hs-CRP) (5.5[1.1-9] vs 9.1[7.4-9.5];P=.007). while white blood cell (WBC) count, lymphocyte count (LC), hemoglobin (Hb) and platelet (PLT) were statistically insignificant (Table 2). We grouped coinfections and non-2019-nCoV infections into one category, and used binary logistic regression analysis to screen independent differential diagnostic indicators for 2019-nCoV alone infections. WBC, N%, L%, NC, LC, hs-CRP and PCT were entered into a backward stepwise multivariate logistic regression model, and the last step was to obtain two independent indicators of NC (P=0.075) and PCT (P<0.001) (Table 3). Goodness of fit testing (Hosmer-Lemeshow test) was used to assess deviations between observed and expected values. A P value of >.05 implies no significant difference between the observed and expected values. The P value of the goodness-of-fit testing of our model is 0.473, and therefore it is acceptable (Figure 1). Analysis of the AUC of the ROC curve was constructed to assess the differentiating performance. The AUC of overall model is 0.817 ([95%CI] [0.719-0.916];P<.001). PCT as a differential diagnostic indicator of 2019-nCoV alone, the AUC is 0.792 ([0.688-0.896];P<.001) (Figure 1, Table 4). Considering the principle of practicability and good accuracy, the PCT cut-off value is optimized and adjusted to 0.1ng/mL, the sensitivity, specificity, PPV, and NPV of differentiating are 65.9%, 78.6%, 82.9%, and 59.2% (Table 5). ![Figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/05/08/2020.04.07.20057315/F1.medium.gif) [Figure 1.](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/F1) Figure 1. The P value of Hosmer-Lemeshow testing of overall model is 0.473. The AUC for overall model and PCT were 0.817 and 0.792, respectively. View this table: [Table 2:](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/T2) Table 2: Comparison of laboratory data between the three groups View this table: [Table 3:](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/T3) Table 3: Independent indictors differentiating 2019-nCoV alone infection View this table: [Table 4:](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/T4) Table 4: Differentiating performance of indictors for 2019-nCoV alone infection View this table: [Table 5:](http://medrxiv.org/content/early/2020/05/08/2020.04.07.20057315/T5) Table 5: Differentiating characteristics of PCT for 2019-nCoV alone infection ## Discussion Every winter and spring, a variety of virus infections are prevalent worldwide, such as parainfluenza, RSV, INF A and B, rhinovirus and cytomegalovirus, etc.8,9 A significant number of community acquired pneumonia (CAP) are caused by viruses, either directly or as part of a coinfection. The clinical picture of these different pneumonias can be very similar, but viral infection is more common in the pediatric populations. Despite great advances in virus detection and pneumonia imaging,4 the identification and differential diagnosis of viral infections has been facing enormous challenges because laboratory detections and radiographic images are not always in agreement with clinical features.10,11 RT-PCR methods based on spike gene and N gene were widely used for detecting viral RNA, and were considered a gold standard for 2019-nCoV confirmed.12–14 However, this method had its limitations, such as false positive or false negative results, time consuming, false sampling, inconsistence of sample collections and preparations. Most importantly, the inaccuracy of RT-PCR method caused problems in timely triage, isolating the source of infection, the following reasonable treatment, early removal of isolation, and improvement of psychological stress in children. In addition, CT changes in novel coronavirus viral pneumonia are nonspecific and difficult to differentiate from other viral infections.6,11 Therefore, it is necessary to start from other clinical features and laboratory data, independent of nucleic acid detection and chest CT, to provide a basis for early differential diagnosis. As a viral infection, it is obvious that children are especially susceptible to 2019-nCoV infection. Most of the infected children we observed are asymptomatic or mildly febrile and or symptoms of ARI.3,15 However, the changes of chest CT are more typical of viral pneumonia,11 which is consistent with the results of other relevant reports. Also, from the 2019-nCoV cases with coinfection, they all had fever and symptoms of ARI, chest CT findings of viral pneumonia were also typical. Therefore, 2019-nCoV with other viral coinfections may be more common in children.6 Pediatric patients should be alert to the possibility of coinfection if severe symptoms appear. Compared with other non-bacterial pathogens,2019-nCoV has more family cluster infections, which indicates that the virus is more infectious and has the ability of sustained human-to-human transmission. When developing preventive and control measures for children, disinfecting droplets and household environment and hand hygiene may be the top priorities.16 For the last two decades, most of studies have been carried out by using, alone or in combination, WBC count, and serum hs-CRP and PCT concentration.17,18 PCT appears to be most effective in selecting bacterial cases and assessing severity. However, the precise cut-offs between the separation of bacteria from viruses and the separation between mild and severe separations have not been established.19 In adults, the normal reference value of PCT is less than 0.1 ng/mL. Between 0.1 and 0.25 ng/mL represents a viral infection. Between 0.25 and 0.5 ng/mL, bacterial or bacterial coinfection is less likely to require antibiotic treatment. Data regarding children, despite being limited, are consistent with those collected in adults. Li Z et al found that serum PCT level could provide a useful method of distinguishing bacterial coinfections from an H1N1 influenza infection alone in children during the early disease phase.20 Chen ZM et al also suggested using a PCT>0.5 ng/mL to identify 2019-nCoV with bacterial coinfections.7 Our investigation also used the criterion of PCT>0.5 ng/mL to exclude bacterial infection or coinfection. Three cases in the non-2019-nCoV group considered bacterial infections, and one case in the 2019-nCoV confirmed group had IFN A coinfection, but the possibility of combined bacterial coinfection cannot be ruled out. Interestingly, the PCT of the other three cases with RSV coinfection in the 2019-nCoV confirmed group was still significantly higher than that of 2019-nCoV infection alone. Limited to laboratory testing methods and personnel during the epidemic, except for 2019-nCoV, our hospital can only perform RT-PCR detection of IFN A, B, RSV and cytomegalovirus. Unidentified nonbacterial infections may be other types of viral infections. It also does not rule out that some 2019-nCoV infections may have these other viral coinfection. There are several limitations in our retrospective cohort study. First, due to the small sample size of the single-center research hospital, in particular, there were only 4 cases in the coinfection group, which may have certain sampling errors. Second, the children may be in different stages of disease when they are admitted to the hospital. Therefore, these results should be carefully interpreted owing to potential selection bias and residual confounding. Larger cohort studies from other cities in China and other countries may also be needed to provide further data support. ## Conclusions Asymptoms or mild symptoms, positive CT findings and family cluster infection are the main clinical features of pediatric patients infected with 2019-nCoV. With moderate efficacy, PCT can provide an important basis for differentiating 2019-nCoV alone and other viral infection or coinfection with other viruses. Although the PCT in the 2019-nCoV alone infection were significantly reduced, compared with other viral infections or viral coinfection, whether the PCT in the true world were reduced, that is, whether they are specific, requires further evidence to support. ## Data Availability All data in this paper is true, reliable and available. ## Acknowledgments Thanks for the approval of the Ethics Committee of The Third People’s Hospital of Shenzhen (2020–123). ## Footnotes * Compliance with Ethical Statements * Conflict of Interest: All authors declare that they have no conflict of interest. * Funding: There is no funding source. * Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors. This investigation was approved by the Ethics Committee of The Third People’s Hospital of Shenzhen (2020–123). Abbreviations : 2019-nCoV : 2019 novel coronavirus AUC : area under curve ARI : acute respiratory infection CI : confidence interval CAP : community acquired pneumonia CT : computed tomography hs-CRP : high sensitivity C-reactive protein Hb : Hemoglobin INFA, B : influenza A, B IQR : interquartile range LC : lymphocyte count L% : percentage of lymphocyte MP : mycoplasma pneumoniae NPV : negative predictive value N% : percentage of neutrophil NC : neutrophil count OR : odds ratio PPV : positive predictive value PLT : platelet PCT : procalcitonin ROC : receiver operating characteristic curve RT-PCR : real-time reverse transcriptase polymerase chain reaction RSV : respiratory syncytial virus SD : standard deviation SE : standard error WBC : white blood cell * Received April 7, 2020. * Revision received May 5, 2020. * Accepted May 8, 2020. * © 2020, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## References 1. 1.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJMoa2001316&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 2. 2.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)30183-5&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 3. 3.Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China. Pediatrics. 2020.pii:e20200702. doi: 10.1542/peds.2020-0702. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTA6InBlZGlhdHJpY3MiO3M6NToicmVzaWQiO3M6MTU6IjE0NS82L2UyMDIwMDcwMiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA1LzA4LzIwMjAuMDQuMDcuMjAwNTczMTUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 4. 4.Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020. doi: 10.1002/jmv.25748. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/jmv.25748&link_type=DOI) 5. 5.The guidelines for diagnosis and treatment of 2019-nCoV infected pneumonia (the sixth edition draft) issued by the National Health Commission of China In. [http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm2020](http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm2020). 6. 6.Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 2020. doi: 10.1002/ppul.24718. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/ppul.24718&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 7. 7.Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, Lin R, Tang LF, Wang TL, Wang W, Wang YS, Xu WZ, Yang ZH, Ye S, Yuan TM, Zhang CM, Zhang YY.. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020. doi: 10.1007/s12519-020-00345-5. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12519-020-00345-5&link_type=DOI) 8. 8.Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, Rath BA, Madhi SA, Campbell S, Vaccari LC, Bulkow LR, Thomas ED, Barnett W, Hoppe C, Campbell H, Nair H. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020416. 9. 9.Baillie VL, Olwagen CP, Madhi SA. Review on Clinical and Molecular Epidemiology of Human Rhinovirus-Associated Lower Respiratory Tract Infections in African and Southeast Asian Children. Pediatr Infect Dis J. 2018;37(7):e185-e194. 10. 10.Kawaguchi A, Bates A, Lee BE, Drews S, Garros D. Virus detection in critically ill children with acute respiratory disease: a new profile in view of new technology. Acta Paediatr. 2018;107(3):504–510. 11. 11.Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, Ji W. Sensitivity of Chest CT for COVID-19:Comparison to RT-PCR. Radiology. 2020:200432. doi:10.1148/radiol.2020200432. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1148/radiol.2020200432&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32073353&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 12. 12.Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020. pii: hvaa029. doi: 10.1093/clinchem/hvaa029. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/clinchem/hvaa029&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32031583&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 13. 13.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)302518&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32007145&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) 14. 14.Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020;92(5):464–467. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/jmv.25702&link_type=DOI) 15. 15.Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, Zhang Y, Zhang H, Jia R, Liu P, Wang X, Ge Y, Xia A, Tian H, Chang H, Wang C, Li J, Wang J, Zeng M.. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020. pii: ciaa198. doi: 10.1093/cid/ciaa198. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/cid/ciaa198&link_type=DOI) 16. 16.Thompson LA, Rasmussen SA. What Does the Coronavirus Disease 2019 (COVID-19) Mean for Families? JAMA Pediatr. 2020. doi: 10.1001/jamapediatrics.2020.0828. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jamapediatrics.2020.0828&link_type=DOI) 17. 17.Kotula JJ, Moore WS, Chopra A, Cies JJ. Association of Procalcitonin Value and Bacterial Coinfections in Pediatric Patients With Viral Lower Respiratory Tract Infections Admitted to the Pediatric Intensive Care Unit. J Pediatr Pharmacol Ther. 2018;23(6):466–472. 18. 18.Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1086/421997&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15307030&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F08%2F2020.04.07.20057315.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000222474300010&link_type=ISI) 19. 19.Principi N, Esposito S. Biomarkers in Pediatric Community-Acquired Pneumonia. Int J Mol Sci. 2017;18(2). pii: E447. doi: 10.3390/ijms18020447. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/ijms18020447&link_type=DOI) 20. 20.Li Z, He L, Li S, He W, Zha C, Ou W, Hou Q, Wang W, Sun X, Liang H. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza. Influenza Other Respir Viruses. 2019;13(2):184–190.